Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
4,244,719
-
Shares change
-
+723,649
-
Total reported value, excl. options
-
$58,616,737
-
Value change
-
+$8,957,096
-
Put/Call ratio
-
2.1%
-
Number of buys
-
40
-
Number of sells
-
-24
-
Price
-
$13.81
Significant Holders of GALECTIN THERAPEUTICS INC - COM NEW (GALT) as of Q2 2014
80 filings reported holding GALT - GALECTIN THERAPEUTICS INC - COM NEW as of Q2 2014.
GALECTIN THERAPEUTICS INC - COM NEW (GALT) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,244,719 shares
.
Largest 10 shareholders include Cormorant Asset Management, LLC (800,000 shares), VANGUARD GROUP INC (501,365 shares), BlackRock Fund Advisors (453,412 shares), BAKER BROS. ADVISORS LP (300,000 shares), BlackRock Institutional Trust Company, N.A. (201,105 shares), DAVIDSON D A & CO (194,158 shares), State Street Corp (170,229 shares), Neuberger Berman Group LLC (163,010 shares), Allianz Asset Management AG (139,285 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (120,630 shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.